Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients
Clinical trial NCT01399008 · COMPLETED
Trial details
- NCT number
- NCT01399008
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2012-02-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.